Zotiraciclib (SB1317, TG02)
目录号: A13454
CDK/JAK2/FLT3 抑制剂
SB1317 是一种强效的 环依赖性激酶(CDKs)、类FMS酪氨酸激酶-3(FLT3)和 雅努斯激酶2(JAK2)抑制剂,其半抑制浓度(IC50)分别为 CDK2 13nM、JAK2 56nM 和 FLT3 73nM。
Discription | SB1317 is a potent inhibitor of Cyclin dependent kinases (CDKs), FMS-like tyrosine kinase-3 (FLT3) and Janus kinase 2 (JAK2) with IC50 values of 13nM, 56nM and 73nM for CDK2, JAK2 and FLT3, respectively. | ||
---|---|---|---|
Targets |
|
目录号 | A13454 |
---|---|
分子式 | C23H24N4O |
分子量 | 372.46 |
CAS号 | 1204918-72-8 |
SMILES | CN(C/C=C/CCOC1=CC=CC2=C1)CC3=CC(NC4=NC=CC2=N4)=CC=C3 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2